Eli Lilly's Retatrutide Achieves Up to 23% Body Weight Loss in Diabetes Trial

Eli Lilly's drug retatrutide demonstrated significant weight loss effects in a diabetes trial, with participants losing up to 23% of their body weight. This represents the highest weight reduction recorded in a drug trial for diabetes patients, particularly among those with higher starting BMI.

Originally published by gnews